Target intelligence / Profile preview

HIV Envelope Protein gp120 (gp120)

Target
gp120
Molecular classification
Glycoprotein, Viral protein, Envelope protein
01

Overview

The HIV envelope protein gp120 is a glycoprotein found on the surface of the Human Immunodeficiency Virus (HIV) envelope. It plays a critical role in viral entry into host cells by mediating attachment to specific cell surface receptors. Gp120 binds primarily to CD4 receptors on helper T-cells but can also interact with DC-SIGN and heparan sulfate proteoglycans. This binding initiates conformational changes necessary for subsequent interaction with chemokine co-receptors (CCR5 or CXCR4), leading to membrane fusion mediated by gp41. Gp120 has an inner domain and an outer domain bridged by a four-stranded antiparallel β-sheet. Gp120 is heavily glycosylated with N-linked glycans that form a "glycan shield," protecting it from immune recognition. Three molecules each of gp120 associate noncovalently with three molecules each of transmembrane protein gp41 to form functional Env spikes on HIV's surface. Variable regions sterically hinder antibody access; conserved neutralizing epitopes are recessed or masked by glycans or variable loops. This structural plasticity allows evasion from broadly neutralizing antibodies despite being immunogenic itself.

02

Mechanism of action

N/A

03

Biological functions

Viral entryReceptor bindingImmune evasion
04

Disease associations

HIV infectionAIDS pathogenesis
05

Safety considerations

High variability leading to immune evasionGlycosylation masking conserved epitopesChallenges in eliciting broadly neutralizing antibodiesMonomeric recombinant forms failing in vaccine trials

Beyond the preview

Go deeper on HIV Envelope Protein gp120 (gp120).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HIV Envelope Protein gp120 (gp120).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call